Sanofi
Customers
0
None disclosed
Suppliers
2
2 active
Top supplier share
36%
of NVAX revenue · FY to 2025-12-31
Top supplier by $
$404.5M
NVAX · FY to 2025-12-31
Latest period
Dec 31, 2025
10-K filed 2026-02-26
Suppliers 2
Companies that disclose SNY as a major customer, as a share of their own revenue. 2 active, 0 lapsed.
| Company | % of their revenue | Est. $ from SNY | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| NVAX NOVAVAX INC |
36% | $404.5M | FY 2025-12-31 | −32.0pp | Active | 10-K 2026-02-26 |
Sanofi 36 % 68 % * 76 % 46 % | ||||||
| BMRN BIOMARIN PHARMACEUTICAL INC |
Named | — | FY 2025-12-31 | — | Active | 10-K 2026-02-26 |
Sanofi is our sole customer for ALDURAZYME and is responsible for distributing, marketing, and selling ALDURAZYME to third parties. | ||||||
Alerts are coming
Get an email when SNY's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.